landiolol has been researched along with esmolol in 29 studies
| Studies (landiolol) | Trials (landiolol) | Recent Studies (post-2010) (landiolol) | Studies (esmolol) | Trials (esmolol) | Recent Studies (post-2010) (esmolol) |
|---|---|---|---|---|---|
| 311 | 85 | 176 | 1,023 | 309 | 266 |
| Protein | Taxonomy | landiolol (IC50) | esmolol (IC50) |
|---|---|---|---|
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.197 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (10.34) | 18.2507 |
| 2000's | 9 (31.03) | 29.6817 |
| 2010's | 16 (55.17) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Atsuki, K; Henmi, S; Imaizumi, K; Imaizumi, Y; Kawasumi, H; Muraki, K; Nagano, N; Nakagawa, H; Nakanishi, T; Tokuno, T; Watanabe, M | 1 |
| Hagihara, A; Hashimoto, K; Motomura, S; Narumi, Y | 1 |
| Hashimoto, K; Sugiyama, A; Takahara, A | 1 |
| Benson, KT; Goto, H; Kindscher, JD; Sasao, J; Taneyama, C; Tarver, SD | 1 |
| Fujita, S; Kanaya, N; Kurosawa, S; Nakayama, M; Namiki, A; Niiyama, Y | 1 |
| Asada, A; Hase, I; Nishikawa, K; Oda, Y | 1 |
| Akihiro, T; Goto, F; Nishihara, F; Nishikawa, K; Obata, H; Saito, S; Yuki, N | 1 |
| Mio, Y | 1 |
| Masaki, E | 1 |
| Goyagi, T; Kimura, T; Masaki, Y; Nishikawa, T; Tobe, Y | 1 |
| Asada, A; Ikeshita, K; Nishikawa, K; Tani, Y; Toriyama, S; Yamada, T; Yamashita, T | 1 |
| Dohi, S; Iida, H; Oda, A; Osawa, Y; Tanahashi, S; Yamaguchi, S | 1 |
| Goyagi, T; Masaki, Y; Nishikawa, T; Tobe, Y; Umehara, S | 1 |
| Goyagi, T; Horiguchi, T; Nishikawa, T; Tobe, Y | 1 |
| Abe, R; Furuya, H; Inoue, S; Kawaguchi, M; Kobayashi, H | 1 |
| Goyagi, T; Nishikawa, T; Tobe, Y | 2 |
| Endo, S; Okamoto, Y; Ono, K; Shibata, S | 1 |
| Goyagi, T; Horiguchi, T; Masaki, Y; Nishikawa, T; Tobe, Y | 1 |
| Birkenhäger, TK; Boere, E; Groenland, TH; van den Broek, WW | 1 |
| Deng, X; Guo, Q; He, J; He, P; Lang, Z; Li, S; Tao, G; Wang, X; Xiao, J; Xue, Z; Yang, T; Zhao, Y; Zou, Q | 1 |
| Kurita, T; Morita, K; Sato, S | 1 |
| Freissmuth, M; Nanoff, C; Nasrollahi-Shirazi, S; Sucic, S; Yang, Q | 1 |
| Hodisch, J; Kadlecová, P; Krumpl, G; Trebs, M; Ulc, I | 1 |
| Hodisch, J; Husch, B; Kadlecová, P; Krumpl, G; Maurer, G; Trebs, M; Ulč, I | 1 |
| Fitzgerald, RD; Frank, G | 1 |
| Landoni, G; Monaco, F; Poveda-Jaramillo, R; Zangrillo, A | 1 |
| Er, F; Gassanov, N | 1 |
| Hodisch, J; Husch, B; Kadlecová, P; Krumpl, G; Trebs, M; Ulč, I | 1 |
5 review(s) available for landiolol and esmolol
| Article | Year |
|---|---|
[New ultra-short-acting beta-blockers: landiolol and esmolol--the effects on cardiovascular system].
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiovascular System; Heart Rate; Humans; Morpholines; Myocardial Ischemia; Propanolamines; Urea | 2006 |
[Antinociceptive effects of landiolol and esmolol].
Topics: Adjuvants, Anesthesia; Adrenergic beta-Antagonists; Analgesics; Animals; Humans; Intubation, Intratracheal; Morpholines; Propanolamines; Urea | 2006 |
Beta-blocking agents during electroconvulsive therapy: a review.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Electroconvulsive Therapy; Humans; Labetalol; Morpholines; Propanolamines; Randomized Controlled Trials as Topic; Urea | 2014 |
Ultra-Short-Acting β-Blockers (Esmolol and Landiolol) in the Perioperative Period and in Critically Ill Patients.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Critical Illness; Heart Rate; Humans; Morpholines; Myocardial Ischemia; Perioperative Period; Propanolamines; Urea | 2018 |
[The Role of Ultrarapid Acting Betablocker Esmolol and Landiolol in Critically Ill Patients].
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Critical Illness; Humans; Morpholines; Propanolamines; Urea | 2019 |
7 trial(s) available for landiolol and esmolol
| Article | Year |
|---|---|
The short-acting beta1-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Double-Blind Method; Electroencephalography; Female; Heart Rate; Humans; Intubation, Intratracheal; Male; Methyl Ethers; Middle Aged; Morpholines; Propanolamines; Sevoflurane; Urea | 2005 |
Landiolol and esmolol prevent tachycardia without altering cerebral blood flow.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anesthesia; Blood Pressure; Cerebrovascular Circulation; Cross-Over Studies; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Electroconvulsive Therapy; Female; Heart Rate; Humans; Male; Middle Aged; Morpholines; Propanolamines; Tachycardia; Ultrasonography, Doppler, Transcranial; Urea | 2005 |
Beta blocker infusion decreases the magnitude of core hypothermia after anesthesia induction.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anesthesia, Inhalation; Body Temperature; Coloring Agents; Female; Gynecologic Surgical Procedures; Hemodynamics; Humans; Hypothermia; Indocyanine Green; Intubation, Intratracheal; Middle Aged; Morpholines; Propanolamines; Urea | 2010 |
Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypotension; Infusions, Intravenous; Intraoperative Complications; Male; Middle Aged; Morpholines; Propanolamines; Tachycardia, Supraventricular; Treatment Outcome; Urea; Young Adult | 2015 |
Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group.
Topics: Adrenergic beta-Antagonists; Adult; Double-Blind Method; Female; Humans; Male; Morpholines; Propanolamines; Prospective Studies; Urea; White People; Young Adult | 2017 |
Pharmacokinetics and Pharmacodynamics of Low-, Intermediate-, and High-Dose Landiolol and Esmolol During Long-Term Infusion in Healthy Whites.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cross-Over Studies; Czech Republic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Healthy Volunteers; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Propanolamines; Prospective Studies; Therapeutic Equivalency; Urea; White People; Young Adult | 2018 |
Blood Pressure Recovery After Dobutamine Antagonism: Partial With Landiolol, None With Esmolol.
Topics: Blood Pressure; Cross-Over Studies; Dobutamine; Humans; Morpholines; Propanolamines; Prospective Studies; Urea | 2022 |
17 other study(ies) available for landiolol and esmolol
| Article | Year |
|---|---|
Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Dose-Response Relationship, Drug; Guinea Pigs; Heart; Male; Membrane Potentials; Morpholines; Propanolamines; Urea | 1996 |
Time course of a new ultrashort-acting beta-adrenoceptor-blocking drug, ONO-1101: comparison with those of esmolol and propranolol by using the canine isolated, blood-perfused heart preparations.
Topics: Adrenergic beta-Antagonists; Animals; Blood; Dogs; Female; Heart; Hemodynamics; In Vitro Techniques; Male; Morpholines; Myocardial Contraction; Perfusion; Propanolamines; Propranolol; Sinoatrial Node; Urea | 1998 |
Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anesthesia; Animals; Anti-Arrhythmia Agents; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Electrocardiography; Female; Hemodynamics; Isoproterenol; Male; Morpholines; Propanolamines; Time Factors; Urea | 1999 |
In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Depression, Chemical; Dose-Response Relationship, Drug; Heart Rate; Male; Morpholines; Propanolamines; Rabbits; Urea | 2001 |
Landiolol, esmolol and propranolol protect from ischemia/reperfusion injury in isolated guinea pig hearts.
Topics: Adrenergic beta-Antagonists; Animals; Guinea Pigs; Heart; In Vitro Techniques; Male; Morpholines; Myocardial Reperfusion Injury; Propanolamines; Propranolol; Time Factors; Urea; Ventricular Function, Left | 2003 |
Beta-adrenoreceptor antagonists attenuate brain injury after transient focal ischemia in rats.
Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics, Inhalation; Animals; Brain; Carbazoles; Carvedilol; Halothane; Ischemic Attack, Transient; Male; Morpholines; Myocardial Infarction; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Tetrazolium Salts; Urea | 2006 |
Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Dose-Response Relationship, Drug; Female; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Morpholines; Myocardial Contraction; Myocardium; Oxygen Consumption; Propanolamines; Rabbits; Urea; Ventricular Function, Left | 2008 |
Comparative effects of ultra-short-acting beta1-blockers on voltage-gated tetrodotoxin-resistant Na+ channels in rat sensory neurons.
Topics: Adrenergic beta-Antagonists; Animals; Drug Resistance; Electrophysiological Phenomena; Ion Channel Gating; Kinetics; Male; Morpholines; Patch-Clamp Techniques; Propanolamines; Rats; Rats, Sprague-Dawley; Sensory Receptor Cells; Sodium Channels; Tetrodotoxin; Time Factors; Urea | 2009 |
Esmolol and landiolol, selective beta1-adrenoreceptor antagonists, provide neuroprotection against spinal cord ischemia and reperfusion in rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Blood Gas Analysis; Hemodynamics; Hindlimb; Male; Morpholines; Motor Activity; Motor Neurons; Movement Disorders; Neuroprotective Agents; Propanolamines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Spinal Cord; Spinal Cord Ischemia; Urea | 2010 |
Post-treatment with selective β1 adrenoceptor antagonists provides neuroprotection against transient focal ischemia in rats.
Topics: Adrenergic beta-Antagonists; Animals; Brain Infarction; Brain Ischemia; Disease Models, Animal; Male; Morpholines; Nerve Degeneration; Neuroprotective Agents; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Treatment Outcome; Urea | 2010 |
Neuroprotective effects and suppression of ischemia-induced glutamate elevation by β1-adrenoreceptor antagonists administered before transient focal ischemia in rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Behavior, Animal; Blood Gas Analysis; Body Temperature; Brain Chemistry; Consciousness Disorders; Extracellular Space; Gait Disorders, Neurologic; Glutamic Acid; Hemodynamics; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Microdialysis; Morpholines; Neuroprotective Agents; Norepinephrine; Pain Threshold; Propanolamines; Rats; Rats, Sprague-Dawley; Reflex; Urea | 2011 |
Direct effects of esmolol and landiolol on cardiac function, coronary vasoactivity, and ventricular electrophysiology in guinea-pig hearts.
Topics: Action Potentials; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Computer Simulation; Dose-Response Relationship, Drug; Guinea Pigs; Heart Rate; Morpholines; Myocytes, Cardiac; Propanolamines; Time Factors; Urea; Ventricular Function, Left | 2012 |
Long-term and spatial memory effects of selective β1-antagonists after transient focal ischaemia in rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Cerebral Infarction; Ischemic Attack, Transient; Male; Maze Learning; Memory; Morpholines; Neuroprotective Agents; Propanolamines; Rats; Rats, Sprague-Dawley; Urea | 2012 |
Neuroprotective effects of selective β-1 adrenoceptor antagonists, landiolol and esmolol, on transient forebrain ischemia in rats; a dose-response study.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Ischemic Attack, Transient; Male; Morpholines; Neuroprotective Agents; Propanolamines; Prosencephalon; Rats; Rats, Sprague-Dawley; Urea | 2012 |
Evaluation of near infrared spectroscopy for detecting the β blocker-induced decrease in cerebral oxygenation during hemodilution in a swine model.
Topics: Adrenergic beta-Antagonists; Animals; Brain; Hemodilution; Hemodynamics; Models, Animal; Monitoring, Physiologic; Morpholines; Oximetry; Oxygen; Propanolamines; Spectroscopy, Near-Infrared; Sus scrofa; Urea | 2015 |
Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Blood Pressure; Cyclic AMP; Drug Partial Agonism; Heart Rate; HEK293 Cells; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Morpholines; Phosphorylation; Propanolamines; Propranolol; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Urea | 2016 |
Advantage of landiolol over esmolol? We doubt it!
Topics: Adrenergic beta-Antagonists; Heart Rate; Humans; Morpholines; Propanolamines; Urea | 2018 |